The U.S. Food and Drug Administration (FDA) has approved BRIXADI, also known as buprenorphine, for people with moderate to severe opioid use disorder. The drug is an extended-release injection for subcutaneous use (CIII), meant to be taken weekly or monthly at a healthcare provider’s office. Brixadi is a form of Medication-Assisted Treatment meant to help
by Bill Arbuckle Depression is quite a common mental health disorder. In Canada alone, one study found that 11.3% of adults indicated meeting the criteria for depression at some point in their life. This mood disorder is characterized by low affect, lack of motivation, hopelessness, low energy, and more. Not only is depression challenging
A harm reduction campaign by Homeless Healthcare in Los Angeles has stirred up controversy by handing out clean pipes for users to smoke methamphetamine. Critics say with the distribution of these supplies, many addicted people won’t ever make it off of Skid Row, choosing instead to live comfortably. Harm reduction advocates say, however, that times
The Biden administration wants the states to use Medicaid funding to provide treatment for opioid use disorder. For many people, this will be a lifesaving treatment that will prevent overdose and intense cravings on the inside and out of corrections. This effort has been accelerated after pilot programs found it helped keep inmates alive once
EMDR (Eye Movement Desensitization and Reprocessing) therapy is a psychotherapy approach primarily used to treat PTSD (Post-Traumatic Stress Disorder) and related conditions. While there is limited research on using EMDR therapy for opioid use disorder (OUD), some studies have suggested that it can help treat this condition. The Research on EMDR for Opioid Use Disorder
The DEA has announced new proposed rules for prescribing buprenorphine, a medication-assisted treatment. The new rules would replace a relatively flexible policy adopted during the early days of the pandemic that expanded MAT treatment to people even if they had never met their doctors in person. The new rules limit who can prescribe medication and
Far too few people are getting the benefit of Medication-Assisted Treatment in America, even though the FDA considers it the gold standard for people with opioid use disorder. While stigma still creates barriers within the medical system, pharmacists may play a unique role in helping access life-changing medications such as Suboxone, also known as buprenorphine.
California's new Campus Opioid Safety Act goes into effect on January 1, 2023. Officials call it a bold measure that will save lives, providing fentanyl and addiction education, information, and Narcan, the FDA-approved opioid overdose reversal drug, on all college campuses in California. What Is the Campus Opioid Safety Act? The Act was recently passed
Scientists have been working on a partial solution to the opioid crisis, experimenting with ways to reduce addiction to medically used fentanyl. Some people addicted to it first had the drug in medical facilities for severe pain such as cancer or spinal injuries. Theoretically, people who are exposed to fentanyl, which has fewer addictive properties,
San Francisco leaders have been struggling to fight the addiction epidemic for years. With newfound poverty from the pandemic, a new era of homelessness and addiction has been ushered in. The Addiction Epidemic On Full Display in San Francisco Never has the addiction epidemic been so visible or vulnerable to the exploits of media clicks.
